Citation Impact

Citing Papers

IL-1 Blockade in Autoinflammatory Syndromes
2014
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Hidradenitis suppurativa: A comprehensive review
2009 Standout
A Study of Musculoskeletal Manifestations in 12 Patients with SAPHO Syndrome
2002
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
2007
Acne vulgaris
2011 Standout
Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndrome
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Recent Advances in Acne Vulgaris Research: Insights and Clinical Implications
2008
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Osteomyelitis
2006
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
2011
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
2003

Works of O. Silbermann-Hoffman being referenced

SAPHO syndrome: A long-term follow-up study of 120 cases
1999
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
2001
Rankless by CCL
2026